Frequently Asked Questions
What is Dr. Reddy's Laboratories?
Dr. Reddy’s Laboratories Limited is an India-based global pharmaceutical company. The Company offers a portfolio of products and services, including active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC). Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. The Company’s segments include Pharmaceutical Services and Active Ingredients, Global Generics, and Others. The Pharmaceutical Services and Active Ingredients segment primarily consists of the Company’s business of manufacturing and marketing APIs and intermediates. The Global Generics segment consists of the Company’s business of manufacturing and marketing prescription and OTC finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics).
What is CAGR?
CAGR stands for Compound Annual Growth Rate. In the stock market, it's a useful metric to measure the compound annual growth rate of an investment over a specific period of time, assuming the profits are reinvested at the end of each year. CAGR shows how much an investment grows each year on average.
What is the 3 year, 5 year and 10 Year CAGR (annualized return) of Dr. Reddy's Laboratories?
CAGR (Compound Annual Growth Rate) of Dr. Reddy's Laboratories is as follows:
- 3 Year CAGR: 12.24%
- 5 Year CAGR: 3.88%
- 10 Year CAGR: 4.09%
What is the 1 year return of Dr. Reddy's Laboratories?
In the past 1 year, Dr. Reddy's Laboratories has given a return of -7.35%.
How often the data is updated on this page?
The Current Market Price (CMP) and CAGR data are updated every 15 minutes during market hours. However, the current month's and current year's returns are updated daily after the market closes.